Clinical Trial Update: Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial updating results comparing Telbivudine to Lamivudine in adults with decompensated chronic hepatitis B and cirrhosis; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis, Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-09-05